Pulmatrix, Inc. (NASDAQ:PULM) Short Interest Update

Pulmatrix, Inc. (NASDAQ:PULM) was the recipient of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 74,900 shares, a growth of 27.8% from the November 30th total of 58,600 shares. Approximately 2.1% of the shares of the company are sold short. Based on an average trading volume of 453,600 shares, the short-interest ratio is currently 0.2 days.

Pulmatrix Trading Up 1.7 %

Shares of NASDAQ:PULM traded up $0.12 during midday trading on Tuesday, hitting $6.98. The stock had a trading volume of 31,095 shares, compared to its average volume of 127,981. Pulmatrix has a 1 year low of $1.55 and a 1 year high of $8.44. The stock has a 50 day moving average price of $4.78 and a two-hundred day moving average price of $3.03. The company has a market capitalization of $25.49 million, a PE ratio of -2.64 and a beta of 1.53.

Wall Street Analysts Forecast Growth

Separately, StockNews.com started coverage on Pulmatrix in a report on Saturday. They issued a “hold” rating on the stock.

About Pulmatrix

Pulmatrix, Inc, a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.